SCHEMBL3346972

SCHEMBL3346972

CC1(C)CC(NNC=O)CC(C)(C)N1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.40
GAA P10253 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
RAD52 P43351 1/20 0.39
GFER P55789 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 2/20 0.38
KDM1A O60341 1/20 0.38
EZH2 Q15910 3/20 0.37
TSHR P16473 2/20 0.37
HTT P42858 1/20 0.36
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3040960 0.78 ADH1B (0.44) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL2901200 0.77 RECQL (0.52) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL9671078 0.71 ALDH1A1 (0.50) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL10777968 0.70 RECQL (0.57) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL10633055 0.70 ALDH1A1 (0.55) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL5698881 0.70 ALDH1A1 (0.55) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL28402532 0.68 POLB (0.57) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL1310223 0.67 RECQL (0.48) RECQLGAAKMT2AALDH1A1MEN1
SCHEMBL28386873 0.67 RECQL (0.37) RECQLGAAKMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL23290758 0.67 POLB (0.56) RECQLGAAKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362254-B2 Method for the production of 4-formylaminopiperidine derivatives BASF SE (DE) 2013-01-29 US disclosed
US-20100160637-A1 METHOD FOR THE PRODUCTION OF 4-FORMYLAMINOPIPERIDINE DERIVATIVES BASF SE (DE) 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160637-A1 METHOD FOR THE PRODUCTION OF 4-FORMYLAMINOPIPERIDINE DERIVATIVES UMPS, PAH, DPYD RECQL 2212/4885GAA 2355/4885KMT2A 2400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.